Cargando…

An overview of the characteristics and quality assessment criteria in systematic review of pharmacoeconomics

BACKGROUND: The systematic review of economic evaluations plays a critical role in making well-informed decisions about competing healthcare interventions. The quality of these systematic reviews varies due to the lack of internationally recognized methodological evaluation standards. METHODS: Nine...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Chen, Xue, Mi, Haotian, Fei, Jialian, Li, Lingli, Zhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870091/
https://www.ncbi.nlm.nih.gov/pubmed/33556056
http://dx.doi.org/10.1371/journal.pone.0246080
_version_ 1783648743759806464
author Min, Chen
Xue, Mi
Haotian, Fei
Jialian, Li
Lingli, Zhang
author_facet Min, Chen
Xue, Mi
Haotian, Fei
Jialian, Li
Lingli, Zhang
author_sort Min, Chen
collection PubMed
description BACKGROUND: The systematic review of economic evaluations plays a critical role in making well-informed decisions about competing healthcare interventions. The quality of these systematic reviews varies due to the lack of internationally recognized methodological evaluation standards. METHODS: Nine English and Chinese databases including the Cochrane Library, PubMed, EMbase (Ovid), NHS economic evaluation database (NHSEED) (Ovid), Health Technology Assessment (HTA) database, Chinese National Knowledge Infrastructure (CNKI), WangFang, VIP Chinese Science & Technology Periodicals (VIP) and Chinese Biomedical Literature Database (CBM) were searched. Two reviewers independently screened studies and extracted data. The methodological quality of the literature was measured with modified AMSTAR. Data were narrative synthesized. RESULTS: 165 systematic reviews were included. The overall methodological quality of the literature was moderate according to the AMSTAR scale. In these articles, thirteen quality assessment tools and 32 author self-defined criteria were used. The three most widely used tools were the Drummond checklist (19.4%), the BMJ checklist (15.8%), the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (12.7%). Others included the Quality of Health Economic Studies (QHES), the Consensus on Health Economic Criteria (CHEC), the checklist of Center for Reviews and Dissemination (CRD), the Philips checklist, the World Health Organization (WHO) checklist, the checklist of Critical Appraisal Skills Program (CASP), the Pediatric Quality Appraisal Questionnaire (PQAQ), the Joanna Briggs Institute (JBI) checklist, Spanish and Chinese guidelines. The quantitative scales used in these literature were the QHES and PQAQ. CONCLUSIONS: Evidence showed that pharmacoeconomic systematic reviews’ methodology remained to be improved, and the quality assessment criteria were gradually unified. Multiple scales can be used in combination to evaluate the quality of economic research in different settings and types.
format Online
Article
Text
id pubmed-7870091
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-78700912021-02-11 An overview of the characteristics and quality assessment criteria in systematic review of pharmacoeconomics Min, Chen Xue, Mi Haotian, Fei Jialian, Li Lingli, Zhang PLoS One Research Article BACKGROUND: The systematic review of economic evaluations plays a critical role in making well-informed decisions about competing healthcare interventions. The quality of these systematic reviews varies due to the lack of internationally recognized methodological evaluation standards. METHODS: Nine English and Chinese databases including the Cochrane Library, PubMed, EMbase (Ovid), NHS economic evaluation database (NHSEED) (Ovid), Health Technology Assessment (HTA) database, Chinese National Knowledge Infrastructure (CNKI), WangFang, VIP Chinese Science & Technology Periodicals (VIP) and Chinese Biomedical Literature Database (CBM) were searched. Two reviewers independently screened studies and extracted data. The methodological quality of the literature was measured with modified AMSTAR. Data were narrative synthesized. RESULTS: 165 systematic reviews were included. The overall methodological quality of the literature was moderate according to the AMSTAR scale. In these articles, thirteen quality assessment tools and 32 author self-defined criteria were used. The three most widely used tools were the Drummond checklist (19.4%), the BMJ checklist (15.8%), the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (12.7%). Others included the Quality of Health Economic Studies (QHES), the Consensus on Health Economic Criteria (CHEC), the checklist of Center for Reviews and Dissemination (CRD), the Philips checklist, the World Health Organization (WHO) checklist, the checklist of Critical Appraisal Skills Program (CASP), the Pediatric Quality Appraisal Questionnaire (PQAQ), the Joanna Briggs Institute (JBI) checklist, Spanish and Chinese guidelines. The quantitative scales used in these literature were the QHES and PQAQ. CONCLUSIONS: Evidence showed that pharmacoeconomic systematic reviews’ methodology remained to be improved, and the quality assessment criteria were gradually unified. Multiple scales can be used in combination to evaluate the quality of economic research in different settings and types. Public Library of Science 2021-02-08 /pmc/articles/PMC7870091/ /pubmed/33556056 http://dx.doi.org/10.1371/journal.pone.0246080 Text en © 2021 Min et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Min, Chen
Xue, Mi
Haotian, Fei
Jialian, Li
Lingli, Zhang
An overview of the characteristics and quality assessment criteria in systematic review of pharmacoeconomics
title An overview of the characteristics and quality assessment criteria in systematic review of pharmacoeconomics
title_full An overview of the characteristics and quality assessment criteria in systematic review of pharmacoeconomics
title_fullStr An overview of the characteristics and quality assessment criteria in systematic review of pharmacoeconomics
title_full_unstemmed An overview of the characteristics and quality assessment criteria in systematic review of pharmacoeconomics
title_short An overview of the characteristics and quality assessment criteria in systematic review of pharmacoeconomics
title_sort overview of the characteristics and quality assessment criteria in systematic review of pharmacoeconomics
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870091/
https://www.ncbi.nlm.nih.gov/pubmed/33556056
http://dx.doi.org/10.1371/journal.pone.0246080
work_keys_str_mv AT minchen anoverviewofthecharacteristicsandqualityassessmentcriteriainsystematicreviewofpharmacoeconomics
AT xuemi anoverviewofthecharacteristicsandqualityassessmentcriteriainsystematicreviewofpharmacoeconomics
AT haotianfei anoverviewofthecharacteristicsandqualityassessmentcriteriainsystematicreviewofpharmacoeconomics
AT jialianli anoverviewofthecharacteristicsandqualityassessmentcriteriainsystematicreviewofpharmacoeconomics
AT linglizhang anoverviewofthecharacteristicsandqualityassessmentcriteriainsystematicreviewofpharmacoeconomics
AT minchen overviewofthecharacteristicsandqualityassessmentcriteriainsystematicreviewofpharmacoeconomics
AT xuemi overviewofthecharacteristicsandqualityassessmentcriteriainsystematicreviewofpharmacoeconomics
AT haotianfei overviewofthecharacteristicsandqualityassessmentcriteriainsystematicreviewofpharmacoeconomics
AT jialianli overviewofthecharacteristicsandqualityassessmentcriteriainsystematicreviewofpharmacoeconomics
AT linglizhang overviewofthecharacteristicsandqualityassessmentcriteriainsystematicreviewofpharmacoeconomics